Dermatology Times, January 2025 (Vol. 46. No. 01)

Explore TikTok hair trends like Jell-O coloring, balayage, ombré, and digital perms, explained by expert Zoe Diana Draelos, MD.

Discover financial strategies and side hustle tips for employed dermatologists to maximize benefits, build retirement wealth, and achieve career success.

Explore the role of immunohistochemical stains in enhancing diagnostic accuracy during Mohs surgery, aiding treatment of challenging skin cancers.

Balancing ethics, aesthetics, and patient expectations is crucial in dermatology to ensure safe, responsible, and ethical care.

Researchers are advancing inclusive trials through ancestry-specific endpoints, focusing on skin tone variability, melanin's role, and precision drug modeling.

Chronic hand eczema poses diagnostic and treatment challenges due to its multifaceted etiology. New therapies like JAK inhibitors offer hope.

DFD-29, FDA-approved in 2024, revolutionizes rosacea management by addressing both erythema and inflammatory lesions with a novel extended-release formulation.

Experts explore innovative therapies, psychosocial impacts, and education strategies for managing atopic dermatitis in a Dermatology Times video series.

Explore systemic psoriasis management, covering obesity, depression, biologics, and innovative treatment approaches.

Christopher Bunick, MD, PhD, is an associate professor of dermatology and physician-scientist at Yale School of Medicine in New Haven, Connecticut.

We're welcoming 2025 with dermatology innovations, expert insights on chronic hand eczema, and new leadership at Dermatology Times.